Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and management proposal.
Gauci ML, Baroudjian B, Bédérède U, Zeboulon C, Delyon J, Allayous C, Madelaine I, Eftekhari P, Resche-Rigon M, Poté N, Paradis V, Durand F, Lebbé C, Roux O, Bouattour M; PATIO group. Gauci ML, et al. Among authors: eftekhari p. Clin Res Hepatol Gastroenterol. 2021 Mar;45(2):101491. doi: 10.1016/j.clinre.2020.06.016. Epub 2020 Aug 6. Clin Res Hepatol Gastroenterol. 2021. PMID: 32773362
Severe gastrointestinal toxicity of MEK inhibitors.
Mourad N, Lourenço N, Delyon J, Eftekhari P, Bertheau P, Allayous C, Ballon A, Pagès C, Allez M, Lebbé C, Baroudjian B; PATIO group. Mourad N, et al. Among authors: eftekhari p. Melanoma Res. 2019 Oct;29(5):556-559. doi: 10.1097/CMR.0000000000000618. Melanoma Res. 2019. PMID: 31095035
Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study.
Gauci ML, Boudou P, Baroudjian B, Vidal-Trecan T, Da Meda L, Madelaine-Chambrin I, Basset-Seguin N, Bagot M, Pages C, Mourah S, Resche-Rigon M, Pinel S, Sassier M, Rouby F, Eftekhari P, Lebbé C, Gautier JF. Gauci ML, et al. Among authors: eftekhari p. Cancer Immunol Immunother. 2018 Aug;67(8):1197-1208. doi: 10.1007/s00262-018-2178-0. Epub 2018 May 28. Cancer Immunol Immunother. 2018. PMID: 29808365 Free PMC article.
Osteopenia and fractures associated with long-term therapy with MEK inhibitors.
Dumas M, Laly P, Gottlieb J, Vercellino L, Paycha F, Bagot M, Baroudjian B, Madelaine I, Basset-Seguin N, Eftekhari P, Pagès C, Lebbé C, Lioté F. Dumas M, et al. Among authors: eftekhari p. Melanoma Res. 2018 Dec;28(6):641-644. doi: 10.1097/CMR.0000000000000490. Melanoma Res. 2018. PMID: 30124538
Agreement between a regional pharmacovigilance centre and an adjudication committee regarding adverse drug reactions on a cohort of hospitalised children.
Pages N, Bounabi A, Boussaha I, Ndiaye M, Portefaix A, Simeon G, Guy C, Stagnara J, Paret N, Vial T, Eftekhari P, Floret D, Gajdos V, Langhendries JP, Bleyzac N, Alberti C, Jacqz-Aigrain E, Nguyen KA, Kassai B; EREMI Group. Pages N, et al. Among authors: eftekhari p. Therapie. 2022 Jul-Aug;77(4):397-404. doi: 10.1016/j.therap.2021.12.014. Epub 2021 Dec 24. Therapie. 2022. PMID: 34998623
First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
Durrieu G, Palmaro A, Pourcel L, Caillet C, Faucher A, Jacquet A, Ouaret S, Perault-Pochat MC, Kreft-Jais C, Castot A, Lapeyre-Mestre M, Montastruc JL; French Network of Pharmacovigilance Centres. Durrieu G, et al. Drug Saf. 2012 Oct 1;35(10):845-54. doi: 10.1007/BF03261980. Drug Saf. 2012. PMID: 22967189
Drug-induced eosinophilic fasciitis: A dual pharmacovigilance analysis.
Teboul A, Chouchana L, Durrieu G, Eftekhari P, Treluyer JM, Mouthon L, Chaigne B. Teboul A, et al. Among authors: eftekhari p. J Am Acad Dermatol. 2022 Jun;86(6):1372-1375. doi: 10.1016/j.jaad.2021.05.030. Epub 2021 May 27. J Am Acad Dermatol. 2022. PMID: 34052335 No abstract available.
88 results